Heart surgery patients benefit from pacing:
This article was originally published in Clinica
Two studies the Journal of the American College of Cardiology (May) have shown that atrial pacing can effectively reduce the incidence of atrial fibrillation in patients who have undergone cardiovascular surgery and shorten their stay in hospital. In one study, epicardial wire electrodes were applied to the atria of 96 patients who had undergone coronary bypass. 48 received pacing from an external pacemaker, while the others acted as controls. Atrial fibrillation occurred in 27% of the control patients, but in only 10% of the paced patients. The second study assessed 154 patients undergoing cardiac surgery who received pacing and beta-blockers or the drug alone. Only 17% of patients who received pacing experienced postoperative fibrillation versus 38% of those who did not.
You may also be interested in...
After a strong first quarter, Japan’s Towa Pharmaceuticals saw stability in its domestic revenues but a drop in revenues from its overseas business in its financial second quarter. After launching a series of molecules in June 2020, the company has lined up 10 launches for December 2020 as well.
Pfizer has revealed launch plans for its Nyvepria pegfilgrastim biosimilar, shortly after receiving formal European Commission approval.
Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.